Yongjun Wang Selected Research

Yongjun Wang Research Topics

Disease

260	Stroke (Strokes) 11/2022 - 01/2006
192	Ischemic Stroke 11/2022 - 01/2006
93	Neoplasms (Cancer) 06/2022 - 05/2008
88	Transient Ischemic Attack 11/2022 - 05/2008
36	Hemorrhage 01/2022 - 06/2006
31	Inflammation (Inflammations) 11/2022 - 01/2006
28	Pathologic Constriction (Stenosis) 01/2022 - 01/2006
22	Atherosclerosis 01/2022 - 09/2008
19	Diabetes Mellitus 01/2022 - 05/2008
17	Cerebral Hemorrhage 05/2022 - 05/2008
16	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 10/2013
15	Insulin Resistance 03/2022 - 03/2005
15	Atrial Fibrillation 01/2022 - 01/2013
13	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2015
12	Hypertension (High Blood Pressure) 01/2022 - 05/2009
11	Myocardial Infarction 01/2022 - 01/2015
10	Cognitive Dysfunction 10/2022 - 09/2012
10	Spinal Cord Injuries (Spinal Cord Injury) 05/2022 - 12/2010
10	Hyperglycemia 01/2022 - 01/2015
10	Infections 05/2021 - 07/2004
9	Brain Ischemia (Cerebral Ischemia) 03/2022 - 12/2012
9	Rheumatoid Arthritis 01/2022 - 08/2014
8	Hematoma 11/2022 - 12/2011
8	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 12/2008
8	Arthritis (Polyarthritis) 01/2022 - 03/2016
8	Breast Neoplasms (Breast Cancer) 02/2021 - 08/2015
7	Prediabetic State (Prediabetes) 08/2022 - 03/2012
7	Embolic Stroke 12/2020 - 01/2013
7	Obesity 01/2020 - 01/2009
7	Peripheral Nerve Injuries 08/2019 - 09/2011
6	Thrombosis (Thrombus) 06/2022 - 01/2014
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2022 - 11/2014
6	Ischemia 01/2022 - 05/2008
6	Crohn Disease (Crohn's Disease) 05/2021 - 08/2014
6	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 07/2015
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 03/2015
6	Carcinoma (Carcinomatosis) 05/2020 - 11/2010
6	Pain (Aches) 03/2019 - 02/2011
6	Ulcerative Colitis 05/2016 - 08/2014
5	COVID-19 02/2022 - 01/2020
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2014
5	Chronic Renal Insufficiency 01/2022 - 01/2014
5	Hemorrhagic Stroke 10/2021 - 07/2013
5	Pneumonia (Pneumonitis) 05/2021 - 08/2014

Drug/Important Bio-Agent (IBA)

68	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022 - 01/2006
59	Clopidogrel (Plavix)FDA Link 11/2022 - 09/2010
47	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 05/2008
34	Pharmaceutical PreparationsIBA 01/2022 - 11/2008
28	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2010
27	TicagrelorIBA 01/2022 - 07/2016
24	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2022 - 02/2009
20	oxidized low density lipoproteinIBA 11/2022 - 06/2011
20	LipidsIBA 05/2022 - 04/2009
20	Proteins (Proteins, Gene)FDA Link 04/2022 - 04/2009
19	ProdrugsIBA 03/2022 - 11/2015
18	C-Reactive ProteinIBA 11/2022 - 01/2013
18	Cytochrome P-450 CYP2C19IBA 11/2022 - 07/2016
16	Liposomes (Liposome)IBA 01/2022 - 05/2016
15	danaparoid (Orgaran)FDA Link 01/2022 - 07/2010
14	Triglycerides (Triacylglycerol)IBA 03/2022 - 01/2006
13	CytokinesIBA 03/2022 - 01/2006
13	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2012
12	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 06/2012
11	LDL CholesterolIBA 11/2022 - 11/2014
11	Interleukin-6 (Interleukin 6)IBA 06/2022 - 02/2014
11	Hemoglobins (Hemoglobin)IBA 06/2022 - 02/2014
11	Indicators and Reagents (Reagents)IBA 05/2022 - 01/2014
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 05/2008
11	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 05/2008
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 04/2013
11	LigandsIBA 01/2021 - 07/2010
9	CholesterolIBA 01/2022 - 09/2008
8	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 09/2010
8	Insulin (Novolin)FDA Link 01/2022 - 03/2005
8	Messenger RNA (mRNA)IBA 09/2020 - 11/2010
7	Peptides (Polypeptides)IBA 01/2022 - 01/2013
7	CateninsIBA 01/2022 - 08/2012
7	AlbuminsIBA 01/2022 - 03/2015
7	DisulfidesIBA 07/2021 - 01/2016
7	Therapeutic UsesIBA 02/2021 - 05/2008
7	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2011
6	Uric Acid (Urate)IBA 01/2022 - 03/2014
6	CreatinineIBA 01/2022 - 01/2014
6	HomocysteineIBA 12/2021 - 07/2010
6	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2013
5	Macrophage Migration-Inhibitory FactorsIBA 05/2022 - 01/2017
5	HDL LipoproteinsIBA 03/2022 - 12/2017
5	SaponinsIBA 03/2022 - 12/2016
5	Long Noncoding RNAIBA 01/2022 - 09/2017
5	Irinotecan (Camptosar)FDA LinkGeneric 10/2021 - 02/2019
5	Glutathione (Reduced Glutathione)IBA 07/2021 - 01/2016

Therapy/Procedure

152	Therapeutics 11/2022 - 05/2008
35	Secondary Prevention 09/2022 - 01/2006
18	Thrombectomy 09/2022 - 06/2016
13	Drug Therapy (Chemotherapy) 01/2022 - 05/2008
11	Stents 10/2021 - 01/2006
8	Length of Stay 01/2019 - 12/2011
6	Remission Induction 07/2016 - 08/2014
5	Immunotherapy 06/2022 - 09/2021
5	Aftercare (After-Treatment) 05/2021 - 02/2009